本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

3.29
-0.0050-0.15%
成交量:94.42万
成交额:309.43万
市值:3.54亿
市盈率:-1.32
高:3.34
开:3.28
低:3.19
收:3.29
52周最高:18.17
52周最低:2.19
股本:1.08亿
流通股本:7,878.63万
量比:0.66
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-2.4930
每股收益(LYR):-2.7292
净资产收益率:-69.65%
总资产收益率:-38.07%
市净率:1.00
市盈率(LYR):-1.20

数据加载中...

2025/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities